Viewing Study NCT03888105

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:27 AM

Ignite Modification Date: 2025-12-26 @ 2:07 AM

Study NCT ID: NCT03888105

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-10-15

First Post: 2019-03-14

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Sponsor: Regeneron Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module